Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Sambucus canadensis, also known as American elderberry, is a North American shrub valued for its bioactive compounds, particularly anthocyanins, which exhibit antioxidant and anti-inflammatory properties [PMID: 20836175, 25744406].
Contexte
Sambucus canadensis (American elderberry) is a plant native to North America [PMID: 27158183, 33297361]. It is increasingly cultivated for its edible and medicinal fruits and flowers [PMID: 27158183].
Usages traditionnels
Elderberry is most often used for influenza and immune stimulation [PMID: 30000895].
Composés actifs
The fruits are rich in anthocyanins (approximately 80% of polyphenol content), including cyanidin-based pigments such as cyanidin 3-O-[6-O-(E-p-coumaroyl-2-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside]-5-O-beta-D-glucopyranoside [PMID: 1367876, 37049909]. Other identified compounds include quercetin, rutin, kaempferol, and isorhamnetin 3-O-glucoside [PMID: 30000895, 39314315].
Mécanisme d'action
Anthocyanins from S. canadensis may exhibit anti-aging effects by inhibiting the PI3K/AKT/mTOR signaling pathway, which promotes the apoptosis of senescent cells and reduces mitochondrial-induced oxidative stress [PMID: 36675036]. Extracts have also demonstrated the ability to inhibit microglial activation, reducing the production of reactive oxygen species (ROS) and nitric oxide (NO) [PMID: 25744406].
Preuves cliniques
Preuve BMild Cognitive Impairment (MCI)
A randomized, double-blind, placebo-controlled trial showed a trend toward better visuospatial construct flexibility in patients consuming American elderberry juice compared to placebo [PMID: 38673938, 40002317]
Preuve DInfectious diseases
S. canadensis extracts demonstrated some degree of antibacterial activity in screening assays [PMID: 12471432]
Sécurité et effets indésirables
The bark, leaves, and root contain sambunigrin, a cyanogenic glycoside that is potentially toxic as it can release cyanide; however, cooked berries do not carry this risk [PMID: 30000895]. Allergic reactions to elderberry preparations have been reported rarely [PMID: 30000895].
Grossesse et allaitement
No data exist on the excretion of elderberry components into breastmilk or on the safety and efficacy of elderberry in nursing mothers or infants [PMID: 30000895].
Synthèse des preuves
Evidence for S. canadensis consists primarily of in vitro studies and preliminary clinical trials. While antioxidant and anti-inflammatory properties are well-supported in laboratory settings, clinical evidence for cognitive improvement in MCI is preliminary and based on small sample sizes.
Sources PubMed
- 1.PMID: 30000895 (2006) — Cyanogenic Glycoside Analysis in American Elderberry. · Molecules (Basel, Switzerland)
- 2.PMID: 20836175 (2007) — Anthocyanins and other polyphenolics in American elderberry (Sambucus canadensis) and European elderberry (S. nigra) cultivars. · Journal of the science of food and agriculture
- 3.PMID: 38211940 (2024) — Elderberry, an Ancient Remedy: A Comprehensive Study of the Bioactive Compounds in Three Sambucus nigra L. Subspecies. · Annual review of food science and technology
- 4.PMID: 27182104 (2015) — 'Marge': a European Elderberry for North American Producers. · Acta horticulturae
- 5.PMID: 37049909 (2023) — Elderberry Extracts: Characterization of the Polyphenolic Chemical Composition, Quality Consistency, Safety, Adulteration, and Attenuation of Oxidative Stress- and Inflammation-Induced Health Disorders.